186 related articles for article (PubMed ID: 7510145)
1. Plasma P-selectin is increased in thrombotic consumptive platelet disorders.
Chong BH; Murray B; Berndt MC; Dunlop LC; Brighton T; Chesterman CN
Blood; 1994 Mar; 83(6):1535-41. PubMed ID: 7510145
[TBL] [Abstract][Full Text] [Related]
2. Soluble P-selectin is present in normal circulation and its plasma level is elevated in patients with thrombotic thrombocytopenic purpura and haemolytic uraemic syndrome.
Katayama M; Handa M; Araki Y; Ambo H; Kawai Y; Watanabe K; Ikeda Y
Br J Haematol; 1993 Aug; 84(4):702-10. PubMed ID: 7692937
[TBL] [Abstract][Full Text] [Related]
3. Plasma beta-thromboglobulin: differentiation between intravascular and extravascular platelet destruction.
Han P; Turpie AG; Genton E
Blood; 1979 Nov; 54(5):1192-6. PubMed ID: 91396
[TBL] [Abstract][Full Text] [Related]
4. Increased serum levels of thrombopoietin in patients with thrombotic thrombocytopenic purpura, idiopathic thrombocytopenic purpura, or disseminated intravascular coagulation.
Hiyoyama K; Wada H; Shimura M; Nakasaki T; Katayama N; Nishikawa M; Shiku H; Tahara T; Kato T
Blood Coagul Fibrinolysis; 1997 Sep; 8(6):345-9. PubMed ID: 9351524
[TBL] [Abstract][Full Text] [Related]
5. The origin of P-selectin as a circulating plasma protein.
Fijnheer R; Frijns CJ; Korteweg J; Rommes H; Peters JH; Sixma JJ; Nieuwenhuis HK
Thromb Haemost; 1997 Jun; 77(6):1081-5. PubMed ID: 9241736
[TBL] [Abstract][Full Text] [Related]
6. [Metastatic prostate cancer complicated with chronic disseminated intravascular coagulopathy causing acute renal failure, mimicking thrombotic thrombocytopenic purpura and hemolytic uremic syndrome: pathomechanism, differential diagnosis and therapy related to a case].
Deme D; Ragán M; Kalmár K; Kovács L; Varga E; Varga T; Rakonczai E
Magy Onkol; 2010 Dec; 54(4):351-7. PubMed ID: 21163766
[TBL] [Abstract][Full Text] [Related]
7. Plasma sFas and sFas ligand levels in patients with thrombotic thrombocytopenic purpura and in those with disseminated intravascular coagulation.
Hori Y; Wada H; Mori Y; Shimura M; Hiyoyama K; Nakasaki T; Nishii K; Tamaki S; Nishikawa M; Deguchi K; Minami N; Shiku H
Am J Hematol; 1999 May; 61(1):21-5. PubMed ID: 10331507
[TBL] [Abstract][Full Text] [Related]
8. Thrombotic Microangiopathies (TTP, HUS, HELLP).
Kappler S; Ronan-Bentle S; Graham A
Hematol Oncol Clin North Am; 2017 Dec; 31(6):1081-1103. PubMed ID: 29078925
[TBL] [Abstract][Full Text] [Related]
9. Platelet-derived microvesicles in thrombotic thrombocytopenic purpura and hemolytic uremic syndrome.
Galli M; Grassi A; Barbui T
Thromb Haemost; 1996 Mar; 75(3):427-31. PubMed ID: 8701402
[TBL] [Abstract][Full Text] [Related]
10. Thrombotic microangiopathies (TTP, HUS, HELLP).
Kappler S; Ronan-Bentle S; Graham A
Emerg Med Clin North Am; 2014 Aug; 32(3):649-71. PubMed ID: 25060255
[TBL] [Abstract][Full Text] [Related]
11. Platelet count and prothrombin time help distinguish thrombotic thrombocytopenic purpura-hemolytic uremic syndrome from disseminated intravascular coagulation in adults.
Park YA; Waldrum MR; Marques MB
Am J Clin Pathol; 2010 Mar; 133(3):460-5. PubMed ID: 20154285
[TBL] [Abstract][Full Text] [Related]
12. Aetiology and pathogenesis of thrombotic thrombocytopenic purpura and haemolytic uraemic syndrome: the role of von Willebrand factor-cleaving protease.
Furlan M; Lämmle B
Best Pract Res Clin Haematol; 2001 Jun; 14(2):437-54. PubMed ID: 11686108
[TBL] [Abstract][Full Text] [Related]
13. Increased plasma thrombomodulin as a vascular endothelial cell marker in patients with thrombotic thrombocytopenic purpura and hemolytic uremic syndrome.
Mori Y; Wada H; Okugawa Y; Tamaki S; Nakasaki T; Watanabe R; Gabazza EC; Nishikawa M; Minami N; Shiku H
Clin Appl Thromb Hemost; 2001 Jan; 7(1):5-9. PubMed ID: 11190905
[TBL] [Abstract][Full Text] [Related]
14. Plasma thrombomodulin as a marker of vascular disorders in thrombotic thrombocytopenic purpura and disseminated intravascular coagulation.
Wada H; Ohiwa M; Kaneko T; Tamaki S; Tanigawa M; Shirakawa S; Koyama M; Hayashi T; Suzuki K
Am J Hematol; 1992 Jan; 39(1):20-4. PubMed ID: 1311143
[TBL] [Abstract][Full Text] [Related]
15. Recent advances in thrombotic thrombocytopenic purpura.
Sadler JE; Moake JL; Miyata T; George JN
Hematology Am Soc Hematol Educ Program; 2004; ():407-23. PubMed ID: 15561695
[TBL] [Abstract][Full Text] [Related]
16. [Thrombotic thrombocytopenic purpura].
Aul C; Scharf RE; Königshausen T; Schneider W
Klin Wochenschr; 1985 Feb; 63(3):123-32. PubMed ID: 4038757
[TBL] [Abstract][Full Text] [Related]
17. Clinical use of beta-thromboglobulin levels in diagnosing and treating consumptive and immune thrombocytopenia.
Rubenstein MD; Wall RT
Am J Hematol; 1981 Jun; 10(4):369-73. PubMed ID: 6166192
[TBL] [Abstract][Full Text] [Related]
18. Plasma von Willebrand Factor Antigen (vWF:AG) and thrombomodulin (TM) levels in Adult Thrombotic Thrombocytopenic Purpura/Hemolytic Uremic Syndromes (TTP/HUS) and bone marrow transplant-associated thrombotic microangiopathy (BMT-TM).
Zeigler ZR; Rosenfeld CS; Andrews DF; Nemunaitis J; Raymond JM; Shadduck RK; Kramer RE; Gryn JF; Rintels PB; Besa EC; George JN
Am J Hematol; 1996 Dec; 53(4):213-20. PubMed ID: 8948657
[TBL] [Abstract][Full Text] [Related]
19. Plasma macrophage colony-stimulating factor and P-selectin levels in malaria-associated thrombocytopenia.
Lee SH; Looareesuwan S; Chan J; Wilairatana P; Vanijanonta S; Chong SM; Chong BH
Thromb Haemost; 1997 Feb; 77(2):289-93. PubMed ID: 9157583
[TBL] [Abstract][Full Text] [Related]
20. Poor outcome in disseminated intravascular coagulation or thrombotic thrombocytopenic purpura patients with severe vascular endothelial cell injuries.
Wada H; Mori Y; Shimura M; Hiyoyama K; Ioka M; Nakasaki T; Nishikawa M; Nakano M; Kumeda K; Kaneko T; Nakamura S; Shiku H
Am J Hematol; 1998 Jul; 58(3):189-94. PubMed ID: 9662269
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]